![]()
李乾斌
— 博士生导师
分享到：
-
教师姓名：李乾斌
-
职称：教授
-
职务：博士生导师
-
教师拼音名称：liqianbin
-
所在单位：湘雅药学院
-
学历：博士研究生毕业
-
入职时间：2010-04-22
-
学位：博士学位
-
毕业院校：山东大学
-
在职信息：在职
-
学科：药学
-
招生学科：药学
- Yao M., Wu Y., Hu X., Feng C., Xu J., Chen Z., Li Q. Design, synthesis, and in vitro anti-renal fibrotic effects of imidazopyridazine-based homeodomain-interacting protein kinase 2 inhibitors. Bioorg Med Chem, 2026, 132: 118456.
- Li, Q., Xu, W. Novel anticancer targets and drug discovery in post genomic age. Curr. Med. Chem. Anticancer Agents 2005, 5(1): 53-63.
- Xu, W., Li, Q. Progress in the development of aminopeptidase N (APN/CD13) inhibitors. Curr. Med. Chem. Anticancer Agents 2005, 5(3): 281-301.
- Li, Q., Fang, H., Xu, W. Novel 3-galloylamido-N'-substituted-2,6 -piperidinedione-N-acetamide peptidomimetics as metalloproteinase inhibitors. Bioorg. Med. Chem. Lett. 2007, 17(10): 2935-2938.
- Li, Q., Al-Ayoubi, A., Guo, T., Zheng, H., Sarkar, A., Nguyen, T., Eblen, S.T., Grant, S., Kellogg, G.E., Zhang, S. Structure-activity relationship (SAR) studies of 3-(2-amino-ethyl)-5-(4-ethoxy-benzylidene)-thiazolidine-2,4-dione: development of potential substrate-specific ERK1/2 inhibitors. Bioorg. Med. Chem. Lett. 2009, 19(21): 6042-6046.
- Li, Q., Fang, H., Wang, X., Hu, L., Xu, W. Novel cyclic-imide peptidomimetics as aminopeptidase N inhibitors. Design, chemistry and activity evaluation. Part I. Eur. J. Med. Chem. 2009, 44(12): 4819-4825.
- Li, Q., Fang, H., Wang, X., Xu, W. Novel cyclic-imide peptidomimetics as aminopeptidase N inhibitors. Structure-based design, chemistry and activity evaluation. II. Eur. J. Med. Chem. 2010, 45(4): 1618-1626.
- Li, Q., Wu, J., Zheng, H., Liu, K., Guo, T.L., Liu, Y., Eblen, S.T., Grant, S., Zhang, S. Discovery of 3-(2-aminoethyl)-5-(3-phenyl-propylidene)-thiazolidine -2,4-dione as a dual inhibitor of the Raf/MEK/ERK and the PI3K/Akt signaling pathways. Bioorg. Med. Chem. Lett. 2010, 20(15): 4526-4530.
- Li, Q., Fang, H., Wang, X., Hu, G., Wang, Q., Xu, W. Novel potent 2,5-pyrrolidinedione peptidomimetics as aminopeptidase N inhibitors. Design, synthesis and activity evaluation. Bioorg. Med. Chem. Lett. 2012, 22(2): 850-853.
- Lv, M., Chen, Z., Hu, G., Li, Q. Therapeutic strategies of diabetic nephropathy: recent progress and future perspectives. Drug Discov. Today 2015, 20(3): 332-346.
教师个人主页
中南大学
访问量：次
返回首页